Delivery Order SPE2DB20D1109-SPE2DB25FP61H
Award Date 8/20/25
Potential Completion Date 8/21/25
Potential Value $4.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,098.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ocella 3 mg-0.03 mg tablets (28-count packaging) on August 12, 2025, with ultimate completion by August 13, 2025. This is a non-set-aside competitively awarded contract for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the Defense Logistics Agency's medical supply...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Ocella 3 mg-0.03 mg tablets (28-count) with a ceiling value of $2,297.55. This is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and represents a non-competitive award to the vendor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,953.38 firm fixed-price contract is for the supply of 4565483040 Ocella 3 mg-0.03 mg tablet 28s, a prescription pharmaceutical product. The contract has an ultimate completion date of August 19, 2024. AmerisourceBergen is a major supplier of pharmaceutical and medical products to the U.S. federal government, including military treatment facilities and...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for OCELLA 3-0.3MG 84S with a ceiling value of $10,618.92. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for ultimate completion on September 12, 2025. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through...
- The Defense Logistics Agency awarded a delivery order valued at $478.46 to Amerisourcebergen Drug Corp under an indefinite-delivery/indefinite-quantity contract vehicle. The delivery order is for 4561868207 OCELLA 3 MG-0.03 MG TABLET 28S to be delivered to a facility in Conshohocken, Pennsylvania by August 21, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corp, which will serve as the prime contractor. The Defense Logistics Agency manages the global supply...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $429 to Amerisourcebergen Drug Corporation for the supply of 3 mg-0.03 mg Ocella tablets. As the prime contractor, Amerisourcebergen will deliver 28 count packages of the oral contraceptive to a facility in Conshohocken, Pennsylvania under a one day period of performance from July 12 to July 13, 2023. The Defense Logistics Agency functions to support America's armed forces by procuring their...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,308.80 Firm Fixed Price delivery order contract is for the supply of OCELLA 3 MG-0.03 MG TABLET 28S, a pharmaceutical product. The contract has an Ultimate Completion Date of August 14, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,445.40, is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The IDC, valued at $999,999,999, serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally....
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a $2,078.57 firm-fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of OCELLA 3 MG-0.03 MG TABLET 28S, a pharmaceutical product, with a period of performance through July 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, serving...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,749.34 delivery order contract is for the supply of OCELLA 3-0.3MG 84S, a pharmaceutical product. The contract is a firm fixed price delivery order with a completion date of August 13, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. The contract is...